WGB.F Integer Holdings Corporation
- Market cap
- EUR 3.84B
- P/E
- 44.5x
- P/B
- 2.45x
- ROE
- 4.3%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.
Is WGB.F undervalued?
Graham numberWGB.F trades 120.2% above its Graham number.
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Integer Holdings Corporation fundamental analysis
No fundamental analysis for Integer Holdings Corporation yet.
Integer Holdings Corporation stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Integer Holdings Corporation
Integer Holdings Corporation operates as a medical device contract development and manufacturing company in the United States, Costa Rica, Puerto Rico, Ireland, and internationally. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures. It also provides car…
Full company profileInteger Holdings Corporation financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 3 quarters up to Sep 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Integer Holdings Corporation annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | 1.33B | 1.56B | 1.72B | 1.85B | 1.80B |
| Gross Profit | 346M | 410M | 459M | 500M | 432M |
| Operating Income | 128M | 175M | 220M | 239M | 153M |
| EBITDA | 198M | 255M | 311M | 292M | 253M |
| Net Income | 66.4M | 90.7M | 120M | 103M | 73.5M |
| EPS | 2.00 | 2.72 | 3.57 | 2.99 | 2.16 |
| Balance Sheet | |||||
| Total Assets | 2.79B | 2.94B | 3.08B | 3.41B | 3.39B |
| Total Liabilities | 1.38B | 1.42B | 1.46B | 1.66B | 1.67B |
| Shareholders' Equity | 1.42B | 1.52B | 1.62B | 1.75B | 1.73B |
| Cash & Short-term Investments | 24.3M | 23.7M | 46.5M | 17.2M | 14.1M |
| Cash Flow | |||||
| Operating Cash Flow | 116M | 180M | 205M | 196M | 161M |
| Capital Expenditure | 74.7M | 120M | 105M | 91.0M | 89.6M |
| Free Cash Flow | 41.7M | 60.3M | 99.8M | 105M | 71.8M |
| Ratios | |||||
| ROE | 4.7% | 6.0% | 7.4% | 5.9% | 4.3% |
| ROA | 2.4% | 3.1% | 3.9% | 3.0% | 2.2% |
| Net Profit Margin | 5.0% | 5.8% | 7.0% | 5.5% | 4.1% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
Integer Holdings Corporation dividends
Integer Holdings Corporation has not paid dividends in the last 4 fiscal years.
Who owns Integer Holdings Corporation
- Insiders 0.97%
- Institutions 99.03%
- Public & others 0.00%
- Shares outstanding 34.0M
- Free float 28.9M
Integer Holdings Corporation company profile
- Company name
- Integer Holdings Corporation
- Ticker
- WGB.F
- Exchange
- Frankfurt Exchange
- Sector
- Healthcare
- Industry
- Medical Devices
- Employees
- 11,000
- Fiscal year end
- December
- Address
- 5830 Granite Parkway, Plano, TX, United States, 75024
- Phone
- 214 618 5243
- Website
- integer.net
About Integer Holdings Corporation
Integer Holdings Corporation operates as a medical device contract development and manufacturing company in the United States, Costa Rica, Puerto Rico, Ireland, and internationally. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures. It also provides cardiac rhythm management products, including implantable pacemakers, implantable cardioverter defibrillators, insertable cardiac monitors, implantable cardiac pacing and defibrillation leads, and heart failure therapies; implanted medical devices, implanted leads, procedure accessories, and external devices; neuromodulation products, such as implantable spinal cord stimulators; and non-rechargeable batteries, feedthroughs, device enclosures, machined components, and lead components and sub-assemblies. In addition, the company offers rechargeable batteries and chargers; orthopedics, minimally invasive surgery, and general surgery devices; and portable medical devices, including patient monitoring, ventilators, portable defibrillators, portable ultrasound, and X-Ray machines. Furthermore, the company provides medical technologies; supplies medical stamped components, and shallow and deep draw casings and assemblies; and epicardial pacing leads. It serves multi-national original equipment manufacturers and affiliated subsidiaries in the cardiac rhythm management, neuromodulation, orthopedics, cardio and vascular, and advanced surgical and portable medical markets. The company provides its products under the Greatbatch Medical and the Lake Region Medical brands. The company was formerly known as Greatbatch, Inc. and changed its name to Integer Holdings Corporation in July 2016. Integer Holdings Corporation was founded in 1970 and is headquartered in Plano, Texas.
Integer Holdings Corporation management
10- Mr. Payman KhalesCEO, President & Director · born 1970
- Mr. Diron SmithExecutive VP & CFO · born 1973
- Ms. Lindsay Krause Blackwood J.D.Senior VP, General Counsel, Chief Ethics & Compliance Officer and Corporate Secretary · born 1977
- Mr. Andrew SennPresident of Growth & Innovation · born 1982
- Mr. Jim StephensExecutive Vice President of Special Projects · born 1974
- Mr. Tom P. ThomasVP, Corporate Controller & Principal Accounting Officer · born 1971
- Ms. Carol RussellVP & Chief Information Officer
- Ms. Kristen Marie Stewart C.F.A.Director of Investor Relations
- Mr. Kirk K. Thor Ph.D.Executive VP & Chief Human Resources Officer · born 1964
- Mr. John HarrisPresident of Global Operations & Manufacturing Technology · born 1960